The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea

REFERENCES

• Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheu-matol. 2006;24:82–91.
   Google Scholar
• Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016–22.
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford). 2011;50:1916–20.
   PubMed Web of Science ®Google Scholar
• Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granuloma-tosis with anti-myeloperoxidase autoantibodies. Kidney Int. 2005;68:2225–9.
   PubMed Web of Science ®Google Scholar
• Holle JU, Laudien M, Gross WL. Clinical manifestations and treatment of Wegener's granulomatosis. Rheum Dis Clin N Am. 2010;36:507–26.
   PubMedGoogle Scholar
• Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype? Nephrol Dial Transpl. 2008;23:3928–31.
   Google Scholar
• Park YB, Kim JY, Linton JA, Jung RI, Lee SK, Shin DH. Clinicopathologic study of Wegener's granulomatosis with special emphasis on early lesions in 10 Korean patients. Yonsei Med J. 2001;42: 46–54.
   Google Scholar
• Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101–7.
   PubMed Web of Science ®Google Scholar
• Devaney KO, Travis WD, Hoffman G, Leavitt R, Lebovics R, Fauci AS. Interpretation of head and neck biopsies in Wegener's granulomatosis: a pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol. 1990;14:555–64.
   PubMed Web of Science ®Google Scholar
• Hellmich B, Flossmann 0, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007;66: 605–17.
   Google Scholar
• Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al. A disease specific activity index for We-gener's granulomatosis: modification of the Birmingham Vas-culitis Activity Score. Arthritis Rheum. 2001;44:912–20.
   PubMed Web of Science ®Google Scholar
• Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40:371–80.
   PubMed Web of Science ®Google Scholar
• Pierrot-Deseilligny Despujol C, Pouchot J, Pagnoux C, Coste J, Guillevin L. Predictors at diagnosis of a first Wegener's granu-lomatosis relapse after obtaining complete remission. Rheuma-tology (Oxford). 2010;49:2181–90.
   Google Scholar
• de Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Develop-ment and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol. 2001;55:31–8.
   Google Scholar
• Suzuki Y, Takeda Y, Sato D, Kanaguchi Y, Tanaka Y, Kobayashi S, et al. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan. Mod Rheumatol. 2010;20:54–62.
   PubMed Web of Science ®Google Scholar
• Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Niille B, Heller M, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long term outcome in 155 patients. Arthritis Rheum. 2000;43: 1021–32.
   Google Scholar
• Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Pre-dicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum. 2004;51: 83–91.
   Google Scholar
• Lamprecht P, Trabandt A, Gross WL. Clinical and immunolog-ical aspects of Wegener's granulomatosis (WG) and other syn-dromes resembling WG. Isr Med Assoc J. 2000;2:621–6.
   Google Scholar
• Holle JU, Gross WL, Latza U, N6lle B, Ambrosch P, Heller M, et al. Improved outcome in 445 patients with Wegener's granu-lomatosis in a German vasculitis center over four decades. Arthritis Rheum. 2011;63: 257–66.
   Google Scholar
• Mueller A, Hon-Ulrich K, Feller AC, Gross WL, Lamprecht P. Immune phenomena in localized and generalized Wegener's granulomatosis. Clin Exp Rheumatol. 2003;21:49–54.
   PubMedGoogle Scholar
• Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–7.
   PubMed Web of Science ®Google Scholar